Cargando…

MYC is downregulated by a mitochondrial checkpoint mechanism

The MYC proto-oncogene serves as a rheostat coupling mitogenic signaling with the activation of genes regulating growth, metabolism and mitochondrial biogenesis. Here we describe a novel link between mitochondria and MYC levels. Perturbation of mitochondrial function using a number of conventional a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaonan, Mofers, Arjan, Hydbring, Per, Olofsson, Maria Hägg, Guo, Jing, Linder, Stig, D'Arcy, Padraig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685744/ https://www.ncbi.nlm.nih.gov/pubmed/29163823 http://dx.doi.org/10.18632/oncotarget.21653

Ejemplares similares

Proteasome-associated deubiquitinases and cancer
por: Mofers, Arjan, et al.
Publicado: (2017)

Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
por: Zhang, Xiaonan, et al.
Publicado: (2015)

Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15
por: Mofers, Arjan, et al.
Publicado: (2019)

Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition
por: Mazurkiewicz, Magdalena, et al.
Publicado: (2017)

Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
por: Pellegrini, Paola, et al.
Publicado: (2020)

Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment
por: Zhang, Xiaonan, et al.
Publicado: (2019)

Iron chelators target both proliferating and quiescent cancer cells
por: Fryknäs, Mårten, et al.
Publicado: (2016)

Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments
por: Zhang, Xiaonan, et al.
Publicado: (2014)

Corrigendum: The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

Author Correction: Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

Cdk2: a key regulator of the senescence control function of Myc
por: Hydbring, Per, et al.
Publicado: (2010)

MYC Modulation around the CDK2/p27/SKP2 Axis
por: Hydbring, Per, et al.
Publicado: (2017)

Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action
por: Gubat, Johannes, et al.
Publicado: (2022)

Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System
por: Selvaraju, Karthik, et al.
Publicado: (2021)

Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II
por: Olofsson, Maria Hägg, et al.
Publicado: (2008)

Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters
por: Fayad, Walid, et al.
Publicado: (2009)

Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases
por: Sun, Chao, et al.
Publicado: (2014)

Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence
por: Bazzar, Wesam, et al.
Publicado: (2020)

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
por: Castell, Alina, et al.
Publicado: (2018)

A drug screening assay on cancer cells chronically adapted to acidosis
por: Pellegrini, Paola, et al.
Publicado: (2018)

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
por: Zhang, Xiaonan, et al.
Publicado: (2021)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
por: Clemente, Valentino, et al.
Publicado: (2020)

Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation
por: Bahram, Fuad, et al.
Publicado: (2015)

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
por: Corno, Cristina, et al.
Publicado: (2022)

Synthesis and bio-properties of 4-piperidone containing compounds as curcumin mimics
por: Girgis, Adel S., et al.
Publicado: (2022)

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
por: Castell, Alina, et al.
Publicado: (2022)

Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells
por: D’Arcy, Padraig, et al.
Publicado: (2014)

Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma
por: Hydbring, Per
Publicado: (2022)

Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients
por: Hydbring, Per
Publicado: (2023)

Targeting gene fusions in non-small cell lung cancer—a ceaseless success story?
por: Hydbring, Per
Publicado: (2023)

Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer()
por: Seo, Jae Ho, et al.
Publicado: (2019)

Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
por: Prince, Eric W., et al.
Publicado: (2016)

Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers
por: Zhang, Xiaonan, et al.
Publicado: (2020)

MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
por: Chen, Pan, et al.
Publicado: (2016)

Diabetes and Covid-19: Clinical implications and novel management strategies
por: D’Arcy, R, et al.
Publicado: (2021)

The long noncoding RNA KCNQ1DN suppresses the survival of renal cell carcinoma cells through downregulating c-Myc
por: Yang, Fan, et al.
Publicado: (2019)

MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression
por: Wong, Thian-Sze, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_akel44vacc0clf7mc9csbpvvti